drugset / Trial / NCT00752596

Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient

NCT00752596

Phase 2 Completed 1 enrolled Forest Laboratories
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label, long term compassionate use study of 125 mg per day of azimilide 2HCl in a patient who completed two other protocols (2000098 and 2001060.

Timeline

Start
2005-09
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Azimilide Small molecule 125 mg